Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Clinical Trial

Review

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase I

Comparative Study

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Multicenter Study

Randomized Controlled Trial

Publication Year

From

Quick links

Individual year

2024

2020

2016

2014

2013

2012

2011

2010

2005

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""HIV Antigens""[mesh_terms]

26 Results

Searching titles within these results

Binding to PI(4,5)P is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants.

Antonella Bugatti, Francesca Caccuri, Federica Filippini, Cosetta Ravelli, Arnaldo Caruso

The Journal of biological chemistry 2024;297(2):100934

Free Full Text

Abstract

Immune control of HIV: the obstacles of HLA and viral diversity.

B D Walker, B T Korber

Nature immunology 2001;2(6):473-5

Full Text

Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge.

Giuseppina Li Pira, Laura Bottone, Federico Ivaldi, Francesco Del Galdo, Francesca Papa, Roberto Accolla, Gerrit Koopman, Gianfranco Abbate, Piergiuseppe De Berardinis, Luciana D'Apice, Raffaele De Palma, Fabrizio Manca

Journal of acquired immune deficiency syndromes (1999) 2005;40(2):132-9

Full Text

Abstract

Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Antonella Bugatti, Cinzia Giagulli, Chiara Urbinati, Francesca Caccuri, Paola Chiodelli, Pasqua Oreste, Simona Fiorentini, Alessandro Orro, Luciano Milanesi, Pasqualina D'Ursi, Arnaldo Caruso, Marco Rusnati

The Journal of biological chemistry 2013;288(2):1150-61

Free Full Text

Abstract

Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation.

H Tian, Y Xiao, L Qin, Y H Chen

Immunobiology 2002;204(4):434-41

Full Text

Abstract

Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications.

Antonella Bugatti, Giulia Paiardi, Chiara Urbinati, Paola Chiodelli, Alessandro Orro, Matteo Uggeri, Luciano Milanesi, Arnaldo Caruso, Francesca Caccuri, Pasqualina D'Ursi, Marco Rusnati

Scientific reports 2020;9(1):15768

Free Full Text

Abstract

Diversity considerations in HIV-1 vaccine selection.

Brian Gaschen, Jesse Taylor, Karina Yusim, Brian Foley, Feng Gao, Dorothy Lang, Vladimir Novitsky, Barton Haynes, Beatrice H Hahn, Tanmoy Bhattacharya, Bette Korber

Science (New York, N.Y.) 2002;296(5577):2354-60

Full Text

Abstract

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.

Nicole Frahm, Allan C DeCamp, David P Friedrich, Donald K Carter, Olivier D Defawe, James G Kublin, Danilo R Casimiro, Ann Duerr, Michael N Robertson, Susan P Buchbinder, Yunda Huang, Gregory A Spies, Stephen C De Rosa, M Juliana McElrath

The Journal of clinical investigation 2012;122(1):359-67

Free Full Text

Abstract

Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults.

Silvia Ratto-Kim, Lawrence D Loomis-Price, Naomi Aronson, Janelle Grimes, Cristin Hill, Chevelle Williams, Raphaelle El Habib, Deborah L Birx, Jerome H Kim

Journal of acquired immune deficiency syndromes (1999) 2003;32(1):9-17

Full Text

Abstract

HIV-1 Matrix Protein p17 and its Receptors.

Arnaldo Caruso, Stefania Marsico, Francesca Caccuri, Simona Fiorentini, Cinzia Giagulli

Current drug targets 2016;17(1):23-32

Full Text

Abstract

HIV-Specific Antibody Responses in HIV-Infected Patients: From a Monoclonal to a Polyclonal View.

Daniela Gallerano, Clarissa R Cabauatan, Elopy N Sibanda, Rudolf Valenta

International archives of allergy and immunology 2016;167(4):223-41

Full Text

Abstract

Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.

G Ferrari, D D Kostyu, J Cox, D V Dawson, J Flores, K J Weinhold, S Osmanov

AIDS research and human retroviruses 2001;16(14):1433-43

Full Text

Abstract

Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping.

Masahiko Mori, Kei Matsuki, Tomoyuki Maekawa, Mari Tanaka, Busarawan Sriwanthana, Masaru Yokoyama, Koya Ariyoshi

PloS one 2013;7(7):e41703

Free Full Text

Abstract

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Riccardo Dolcetti, Cinzia Giagulli, Wangxiao He, Marina Selleri, Francesca Caccuri, Lindsay M Eyzaguirre, Pietro Mazzuca, Silvia Corbellini, Federica Campilongo, Stefania Marsico, Emanuela Giombini, Elena Muraro, Gabriella Rozera, Paolo De Paoli, Antonino Carbone, Maria Rosaria Capobianchi, Giuseppe Ippolito, Simona Fiorentini, William A Blattner, Wuyuan Lu, Robert C Gallo, Arnaldo Caruso

Proceedings of the National Academy of Sciences of the United States of America 2016;112(46):14331-6

Free Full Text

Abstract

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.

Amanda Cobb, Lee K Roberts, A Karolina Palucka, Holly Mead, Monica Montes, Rajaram Ranganathan, Susan Burkeholder, Jennifer P Finholt, Derek Blankenship, Bryan King, Louis Sloan, A Carson Harrod, Yves Lévy, Jacques Banchereau

Journal of immunological methods 2011;365(1-2):27-37

Full Text

Abstract

Results: 1 – 15 / 26

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""HIV Antigens""[mesh_terms]

Binding to PI(4,5)P is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants.

Immune control of HIV: the obstacles of HLA and viral diversity.

Human naive CD4 T-cell clones specific for HIV envelope persist for years in vivo in the absence of antigenic challenge.

Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation.

Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications.

Diversity considerations in HIV-1 vaccine selection.

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.

Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults.

HIV-1 Matrix Protein p17 and its Receptors.

HIV-Specific Antibody Responses in HIV-Infected Patients: From a Monoclonal to a Polyclonal View.

Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.

Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping.

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.

Results for
""HIV Antigens""[mesh_terms]